Breaking News

Juniper Biologics Establishes Global Headquarters in Singapore

Will go towards supporting the company’s plan to build out a patient-centric presence throughout key markets in the region and around the globe.

Author Image

By: Charlie Sternberg

Associate Editor

Juniper Biologics, a specialty healthcare company focused on commercializing novel therapies, has established its Global Headquarters in Singapore, from where it will continue the expansion of its global operations.   This announcement was supported by the Singapore Economic Development Board (EDB) who congratulated Juniper Biologics on the significance of this milestone. Juniper Biologics is backed by The Sylvan Group, an independent private equity investment firm focused on deep value compan...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters